- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01434407
Effects of Advanced Glycation Endproducts on Satiety and Inflammation (AGE-1)
September 3, 2012 updated by: AAstrup, University of Copenhagen
Crossover Meal Study Investigating Effects of Advanced Glycation Endproducts on Satiety and Inflammation
The purpose of the meal study is to investigate acute effects on satiety and inflammation of advanced glycation endproducts (AGE) in healthy overweight subjects.
The AGE content of the meal is affected by food preparation methods: frying/grilling versus boiling/steaming.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Frederiksberg C
-
Copenhagen, Frederiksberg C, Denmark, 1958
- Department of Human Nutrition, University of Copenhagen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy males and females between 20 and 50 years old
- BMI 25-40
- Waist circumference above 88 cm for women and above 102 cm for men
Exclusion Criteria:
- Exercise training above 8 hour/week
- Smoking
- Pregnant or breast-feeding women
- Post-menstrual women
- Regular use of medicine (except contraceptive pills)
- Previous gastric bypass surgery
- Donation of blood within the last 3 months
- Involvement in other clinical trials
- Allergic to paraaminobenzoic acid
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low AGE meal
Test meal prepared by boiling/steaming the food
|
Test meals with different AGE content made by different cooking methods
|
|
Experimental: High AGE meal
Test meal prepared by frying/grilling the food
|
Test meals with different AGE content made by different cooking methods
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appetite sensation
Time Frame: Every 30 min up to 5 hours after test meal
|
Appetite sensation measured by visual analogue scales
|
Every 30 min up to 5 hours after test meal
|
|
Plasma ghrelin
Time Frame: Continuous measurement up to 5 hours after test meal
|
Continuous measurement up to 5 hours after test meal
|
|
|
Plasma GLP-1
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
|
Plasma PYY
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
|
Plasma insulin
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
|
Plasma glucose
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
|
Urine AGE
Time Frame: From 24 hour before to 48 hour after test meal
|
From 24 hour before to 48 hour after test meal
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Plasma triglycerides
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
Expression of genes related to AGE
Time Frame: Continuous measurements up to 24 hours after test meal
|
Continuous measurements up to 24 hours after test meal
|
|
IL-1 beta
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
IL-6
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
TNF-alpha
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
CRP
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
VCAM
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
ICAM
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
MIF
Time Frame: Continuous measurements up to 5 hours after test meal
|
Continuous measurements up to 5 hours after test meal
|
|
Plasma AGE
Time Frame: Continuous measurements up to 48 hours after test meal
|
Continuous measurements up to 48 hours after test meal
|
|
Urine isoprostanes
Time Frame: From 24 hour before to 24 hours after test meal
|
From 24 hour before to 24 hours after test meal
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Susanne G Bügel, Department of Human Nutrition, University of Copenhagen
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
September 13, 2011
First Submitted That Met QC Criteria
September 13, 2011
First Posted (Estimate)
September 14, 2011
Study Record Updates
Last Update Posted (Estimate)
September 5, 2012
Last Update Submitted That Met QC Criteria
September 3, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M200
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Dietary meal intervention
-
University of CopenhagenDanish Agriculture and Food CouncilCompletedObesity | Bone MetabolismDenmark
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...CompletedDiabetes Mellitus, Type 2
-
University of TurkuUniversity of Eastern FinlandActive, not recruitingOverweight and Obesity | High Blood Pressure | High Cholesterol/HyperlipidemiaFinland
-
University of ConnecticutAcademy of Nutrition and Dietetics; Hartford HealthCare; Seafood Industry Research... and other collaboratorsCompletedDepression | Pain | Breast Cancer | Fatigue | Stress | Sleep Disturbance | Dietary Habits | SurvivorshipUnited States
-
Imperial College LondonRecruitingHealthy Volunteers | Blood Glucose | Wearables | Metabolism | Energy Intake | Digestion | Dietary Intake AssessmentUnited Kingdom
-
Bispebjerg HospitalCompleted
-
Swiss Distance University of Applied SciencesSwiss Federal Institute of TechnologyRecruitingIron Deficiency (Without Anemia)Switzerland
-
Ankara Medipol UniversityCompletedMeal Frequency | Perceived Stress | Obesity & Overweight | Weight Cycling | Dietary Self-efficiacyTurkey (Türkiye)
-
Clinical Nutrition Research Centre, SingaporeCompletedBlood Pressure | Heart Rate | Thermogenesis | Effects of; FoodSingapore
-
Vanderbilt UniversityNational Institute on Aging (NIA)Completed